Skip to main navigation Skip to search Skip to main content

Whole genome sequence analysis of blood lipid levels in >66,000 individuals

  • NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
  • Massachusetts General Hospital
  • The Broad Institute of MIT and Harvard
  • Harvard University
  • University of Pennsylvania
  • University of Alabama at Birmingham
  • University of Washington
  • National Taiwan University
  • National Health Research Institutes Taiwan
  • University of Texas Rio Grande Valley
  • Washington University St. Louis
  • University of Texas Health Science Center at Houston
  • Wake Forest University
  • University of North Carolina at Chapel Hill
  • The Lundquist Institute
  • Boston University
  • Veterans General Hospital-Taipei
  • Tulane University
  • Johns Hopkins University
  • University of Colorado Anschutz Medical Campus
  • George Washington University
  • University of Virginia
  • Icahn School of Medicine at Mount Sinai
  • University of Maryland, Baltimore
  • Ministry of Health
  • University of Michigan, Ann Arbor
  • Lutia i Puava ae Mapu i Fagalele
  • University of Vermont
  • University of Minnesota Twin Cities
  • University of Science and Technology of China
  • Northwestern University

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Blood lipids are heritable modifiable causal factors for coronary artery disease. Despite well-described monogenic and polygenic bases of dyslipidemia, limitations remain in discovery of lipid-associated alleles using whole genome sequencing (WGS), partly due to limited sample sizes, ancestral diversity, and interpretation of clinical significance. Among 66,329 ancestrally diverse (56% non-European) participants, we associate 428M variants from deep-coverage WGS with lipid levels; ~400M variants were not assessed in prior lipids genetic analyses. We find multiple lipid-related genes strongly associated with blood lipids through analysis of common and rare coding variants. We discover several associated rare non-coding variants, largely at Mendelian lipid genes. Notably, we observe rare LDLR intronic variants associated with markedly increased LDL-C, similar to rare LDLR exonic variants. In conclusion, we conducted a systematic whole genome scan for blood lipids expanding the alleles linked to lipids for multiple ancestries and characterize a clinically-relevant rare non-coding variant model for lipids.

Original languageEnglish
Article number5995
JournalNature Communications
Volume13
Issue number1
DOIs
StatePublished - Dec 2022

Fingerprint

Dive into the research topics of 'Whole genome sequence analysis of blood lipid levels in >66,000 individuals'. Together they form a unique fingerprint.

Cite this